AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 44 filers reported holding AURA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,000 | +4.3% | 5,452 | +41.0% | 0.00% | – |
| Q2 2023 | $47,000 | +291.7% | 3,866 | +192.2% | 0.00% | – |
| Q1 2023 | $12,000 | -57.1% | 1,323 | -50.7% | 0.00% | – |
| Q4 2022 | $28,000 | +600.0% | 2,681 | +1102.2% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 223 | +116.5% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 103 | -70.1% | 0.00% | – |
| Q1 2022 | $8,000 | -57.9% | 345 | -70.2% | 0.00% | – |
| Q4 2021 | $19,000 | – | 1,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
| Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
| Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
| Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
| Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
| CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
| Concord Wealth Partners | 150 | $3,000 | 0.00% |
| Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
| FMR LLC | 471,300 | $8,003,000 | 0.00% |